Octapharma AG - Company & Market Research Reports

Home /
Companies /
Octapharma AG

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

REFINE BY

KEYWORD

Human Coagulation Factor VIII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
111 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Human Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
88 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Human serum albumin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
101 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Human Coagulation Factor IV Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Fibrinogen Deficiency Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
82 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hypofibrinogenemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€1138EUR$1,250USD£966GBP

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
297 Pages
Global

€4546EUR$4,995USD£3,861GBP

Coagulation Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
120 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Human Albumin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
95 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Blood Coagulation Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
113 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Hemophilia Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
November 2023
117 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Recombinant Coagulation Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
November 2023
108 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Blood Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
November 2023
95 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Intravenous Immunoglobulin Market Report and Forecast 2023-2031

 Report
May 2023
140 Pages
Global

From

€4504EUR$4,949USD£3,826GBP

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8530EUR$9,700USD£7,000GBP

Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
June 2022
198 Pages
Global

From

€2202EUR$2,419USD£1,870GBP

€3146EUR$3,456USD£2,672GBP

Human Coagulation Factor IX Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
119 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Plasma-derived Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
101 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Recombinant Antihemophilic Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
93 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Recombinant Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
96 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

261 Results (Page 5 of 14)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.